Infographic | October 20, 2022

The Changing Landscape Of Clinical Monitoring

business meeting with medical practitioner GettyImages-1383959854

About the Survey:

Industry Standard Research (ISR) conducted a web-based quantitative survey with 70 participants involved with clinical development clinical monitoring within pharmaceutical, biopharma, biotech, and/or a contract research organizations. This survey was conducted in April/May 2022.


  • Respondents reported their companies still use on-site monitoring in a majority of trials, 8 out of 10 on average, but expect this proportion to decrease over the next two years being replaced with central and remote monitoring elements.
  • Usage of central monitoring and remote source document review are predicted to increase the most, by 16 and 15 percentage points, respectively, over the next two years.
  • Respondents noted reasons for not using some of these clinical monitoring elements including they felt more confident with 100% SDV / SDR or that their organizations were slower to adopt remote and centralized monitoring practices.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader

Medidata, a Dassault Systemes company